DarioHealth Corp
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
DRIO$2.06-13.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Interim Consolidated Balance Sheets
U.S. dollars in thousands
| | | | | | | |
|---|---|---|---|---|---|---|
| · · September 30, · · December 31, | ||||||
| · 2024 · 2023 | ||||||
| | | Unaudited | | |||
| ASSETS | | | | | | |
| | | | | | | |
| CURRENT ASSETS: · · | ||||||
| Cash and cash equivalents | | $15,547 | | $36,797 | ||
| Short-term restricted bank deposits | | 863 | | 292 | ||
| Trade receivables, net | | 4,948 | | 3,155 | ||
| Inventories | | 4,742 | | 5,062 | ||
| Other accounts receivable and prepaid expenses | | 3,428 | | 2,024 | ||
| | | | | | | |
| Total current assets | | 29,528 | | 47,330 | ||
| | | | | | | |
| NON-CURRENT ASSETS: | | | | | ||
| Deposits | | | 6 | | | 6 |
| Operating lease right of use assets | | 1,306 | | 967 | ||
| Long-term assets | | | 108 | | | 143 |
| Property and equipment, net | | | 1,235 | | | 899 |
| Intangible assets, net | | | 20,343 | | | 5,404 |
| Goodwill | | | 57,427 | | | 41,640 |
| | | | | | | |
| Total non-current assets | | | 80,425 | | | 49,059 |
| | | | | | | |
| Total assets | | $109,953 | | $96,389 | ||
INTERIM CONSOLIDATED BALANCE SHEETS
| | | | | | | |
|---|---|---|---|---|---|---|
| · · September 30, · · December 31, | ||||||
| · 2024 · 2023 | ||||||
| · · Unaudited · · · | ||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY · · · · | ||||||
| | | | | | | |
| CURRENT LIABILITIES: · · | ||||||
| Trade payables | | $2,655 | | $1,131 | ||
| Deferred revenues | | 1,118 | | 997 | ||
| Operating lease liabilities | | | 596 | | | 111 |
| Other accounts payable and accrued expenses | | 5,807 | | 6,300 | ||
| Current maturity of long-term loan | | | 8,670 | | | 3,954 |
| | | | | | | |
| Total current liabilities | | 18,846 | | 12,493 | ||
| | | | | | | |
| NON-CURRENT LIABILITIES | | | | | | |
| Operating lease liabilities | | 1,033 | | 885 | ||
| Long-term loan | | 20,187 | | 24,591 | ||
| Warrant liability | | | 11,327 | | | 240 |
| Other long-term liabilities | | 49 | | 36 | ||
| | | | | | | |
| Total non-current liabilities | | | 32,596 | | | 25,752 |
| | | | | | | |
| STOCKHOLDERS’ EQUITY | | | | | ||
| Common stock of $0.0001 par value - authorized: 160,000,000 shares; issued and outstanding: 31,323,906 and 27,191,849 shares on September 30, 2024 and December 31, 2023, respectively | | 3 | | 3 | ||
| Preferred stock of $0.0001 par value - authorized: 5,000,000 shares; issued and outstanding: 40,156 and 18,959 shares on September 30, 2024 and December 31, 2023, respectively | | *) - | | *) - | ||
| Additional paid-in capital | | 436,590 | | 407,502 | ||
| Accumulated deficit | | (378,082) | | (349,361) | ||
| | | | | | | |
| Total stockholders’ equity | | 58,511 | | 58,144 | ||
| | | | | | | |
| Total liabilities and stockholders’ equity | | $109,953 | | $96,389 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.